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DDX59 belongs to the DEAD-box helicase subfamily, and mutations in DDX59 are 
associated with Oral-facial-digital syndrome (OFDS) that is characterized by malformations 
of the face, oral cavity, and digits.  DDX59 is one of the sixteen genes that have been reported 
to be involved in various subtypes of OFDS.  Most OFDS-associated proteins are localized 
primarily to cilia components, and influencing ciliogenesis and ciliary functions.  However, 
the effect of DDX59 mutations in OFDS and their links to ciliogenesis remained unidentified.  
In this study, we overexpressed the human DDX59 gene in bacteria and purified the protein 
using nickel affinity and size exclusion chromatography.  The DDX59 protein identity was 
confirmed by Western blotting analysis using a DDX59 protein specific-antibody.  Although 
the protein sequence and domain organizations suggest DDX59 is an RNA helicase, 
surprisingly, our in vitro helicase assays revealed that DDX59 was ineffective on the RNA 
substrates tested.  In contrast, DDX59 exhibited ATP dependent 3′→5′ DNA helicase activity. 
Interestingly, the OFDS-associated DDX59 mutations, V367G and G534R, reduced the DNA 
helicase activity, indicating that the loss-of-function might be the underlying cause of OFDS.  
Using the CRISPR/Cas9 system, an attempt to generate DDX59 knockout in the human retinal 
pigmented epithelial (RPE1) cell line resulted in heterozygous knockouts, but not the 
homozygous knockouts, indicating DDX59 is essential for the cell survival.  In spite of 
retaining only one wild-type allele, our immunofluorescence analysis showed a remarkable 
decrease in the number of ciliated cells upon DDX59 depletion, suggesting that DDX59 is 
necessary for the formation of primary cilia.  Taken together, we found that DDX59 is an 
ATP dependent 3′→5′ DNA helicase and an ineffective RNA helicase, and that its loss-of-
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Helicases are a large group of enzymes that mediate the nucleoside triphosphate-dependent 
unwinding of nucleic acid double strands, a necessary step in genome replication, gene 
expression, recombination, and repair.  To effectively unwind a nucleic acid double strand, it 
is widely considered that helicases first bind to one single strand called the loading strand and 
translocate along this strand to cause separation of the nucleic acid double strand (Xu, 2003). 
Studies on the helicase-nucleic acid-binding mechanism have shown that helicases 
exclusively unwind a nucleic acid double strand containing a single-stranded region in a 
strictly defined orientation relative to the 5' or 3' end of the nucleic acid double strand. 
Helicases translocating in the 3'→5' orientation require the single strand on the 3' end (Figure 
1A), while those translocating in the 5'→3' orientation require the single strand on the 5' end 
(Figure 1B) (Lohman and Bjornson, 1996; Patel and Donmez, 2006; Singleton et al., 2007). 
However, some helicases have been shown to unwind the nucleic acid double strand 
irrespective of the single-stranded region (Wong et al., 2013; Xie et al., 2013). 
 
Figure 1.  Helicase unwinding directionality. 
(A) 3'→5' helicase; (B) 5'→3' helicase.  Modified from Xie et al., 2013. 
Helicases that unwind DNA substrates are termed DNA helicases while those that 
unwind RNA substrates are termed RNA helicases, but helicases that unwind both DNA and 
RNA substrates have been described (Kikuma et al., 2004; Talwar et al., 2017; Tutej et al., 
2014; Tuteja et al., 2014).  DNA helicases are involved in all aspects of DNA metabolism, 
such as DNA replication, DNA repair, DNA recombination, gene transcription, and telomere 
















helicases play in biological processes, numerous genetic diseases have been linked to 
mutations in DNA helicases (Croteau et al., 2014; Vannier et al., 2014).  RNA helicases are 
ubiquitously expressed in eukaryotes and function in every step of RNA metabolism from 
transcription to degradation (Bleichert and Baserga, 2007).  While many RNA helicases 
actively unwind a double-stranded RNA, some function by stabilizing the interaction of a 
protein or protein-RNA complex (Tanner and Linder, 2001).  Due to their ubiquitous presence 
and functional importance, many RNA helicases are essential for cell viability and are tightly 
regulated by intramolecular (single protein through oligomerization and/or conformational 
change) and intermolecular (through protein-protein interaction) mechanisms by changing 
positions on the RNA and breaking RNA-Protein complexes using the energy derived from 
ATP binding or hydrolysis  (Jankowsky, 2011; Jarmoskaite and Russell, 2014; Linder and 
Jankowsky, 2011). 
1.2. Mechanisms of helicase translocation and unwinding 
Differences that exist between the helicase mechanisms of translocation and unwinding 
include oligomeric state, directionality, translocation rate, step size, ATP-coupling 
stoichiometry, processivity, and active versus passive.  Some helicases can function as 
monomers, dimers, hexameric, or non-hexameric oligomers (Patel and Donmez, 2006).  Some 
helicases can translocate along the nucleic acid single strand as monomers but lack unwinding 
activities suggesting that the oligomeric state is critical for helicase mechanism.  The step size 
provides insight into the mechanism of helicase action (Lohman et al., 2008).  The helicase 
step size is defined and measured in different ways.  The physical step size is the length of 
base pairs (bp) that a helicase unwinds in one cycle of activity.  The mechanical step size is 
also known as the chemical step size, is the number of bp unwind per ATP hydrolysis event. 
The kinetic step size is measured by a single turnover nucleic acid double strand-unwinding 
or nucleic acid single strand-translocation experiment and is defined as the average number 
of bp unwound or nucleotides translocated between two successive rate-limiting steps in the 
unwinding or translocation cycle (Ali and Lohman, 1997; Lucius et al., 2003). 
 Several studies have established that helicases translocate and unwind a nucleic acid 
double strand in an ATP-dependent fashion (Enemark and Joshua-Tor, 2006; Gai et al., 2004; 
Thomsen and Berger, 2009).  However, it is unclear how translocation and unwinding 
processes are coupled (Manosas et al., 2010).  Nucleic acid double strand unwinding 
mechanisms could be classified either as passive or active (Amaratunga and Lohman, 1993; 
3 
 
Betterton and Jülicher, 2005) (Figure 2).  In the passive mechanism (Figure 2A), the helicase 
interacts with a nucleic acid single strand and translocates unidirectionally and thus stabilizes 
nucleic acid single strand that has resulted from the transient bp opening and closing 
fluctuations of the upstream nucleic acid double strand.  In the active mechanism (Figure 
2B), the helicase interacts directly with the nucleic acid double strand and facilitates nucleic 
acid double strand destabilization.  The activation energy barrier (ΔG),  of an unwinding 
reaction, is lowered by helicases (Abdelhaleem, 2010; Patel and Donmez, 2006; Wu and 
Spies, 2013).  Factors such as nucleic acid sequence or the tension force (F) on the fork that 
controls ΔG may affect the unwinding activity of helicases (Donmez and Patel, 2008; 
Manosas et al., 2010; Schlierf et al., 2019; Syed et al., 2014).  In a passive helicase, the 
unwinding activity is limited by a significant ΔG and is dependent on the nucleic acid GC 
nucleotide sequence.  In an active helicase, the unwinding activity does not have to overcome 
a significant ΔG and is only independent on the nucleic acid GC nucleotide sequence (Lionnet 
et al., 2007; Lohman and Bjornson, 1996; Manosas et al., 2010). 
 
Figure 2.  Passive versus active helicase mechanisms. 
(A) A passive helicase has to overcome a significant activation energy barrier ΔG to proceed 
with a nucleic acid double strand unwinding.  The rate of unwinding depends on factors such 
as the nucleic acid sequence or the tension force (F) that destabilizes the nucleic acid double 
strand fork.  (B) An active helicase can destabilize the nucleic acid double strand and 
effectively reduce the kinetic barrier to fork melting.  An active helicase will unwind at a 














1.3.  Superfamily 2 helicases 
Helicases are classified into six superfamilies (SFs), which are designated SF1–SF6 (Figure 
3) by their characteristic sequence motifs (Gorbalenya and Koonin, 1993).  These SFs share 
structural resemblances in their three-dimensional structures, with RecA1 and RecA2 
domains constituting the helicase domain (Jankowsky and Fairman, 2007; Singleton et al., 
2000; Subramanya et al., 1996).  The RecA-like domain evolved from a 38 kDa structurally 
characterized protein in bacteria known as Rec A (Horii et al., 1980; Story et al., 1992), which 
is critical for the repair and maintenance of DNA (Courcelle and Hanawalt, 2003).  The SF1 
and SF2 helicases are most closely related and classically contain numerous sequence motifs 
with the NTP binding site found at the interface of the RecA1 and RecA2 domains (Fairman-
Williams et al., 2010).  Most SF1 and SF2 helicases are suggested to function by the inchworm 
model mechanisms (Velankar et al., 1999; Singleton et al., 2007; Lee and Yang, 2006; Sarlós 
et al., 2012).  This model includes coordinated and alternated binding to a nucleic acid double 
strand at different binding sites of the helicase as monomers, dimers or higher order-oligomers 
(Cheng et al., 2001; Mackintosh and Raney, 2006). 
 
Figure 3.  A schematic representation of the core helicase domains of six SFs helicases. 
The N-terminal RecA 1 and C-terminal RecA2 are represented by white cylinders. Conserved 
amino acid motifs are colored according to the helicase function.  Motifs in yellow are 
involved in NTP binding and hydrolysis, motifs in green are associated with translocation, 
and motifs in blue interact with the nucleic acid.  Motifs that are unique to specific SFs are 
highlighted in the red oval.  The Walker A (A), Walker B (B), and arginine finger (R) motifs 
are conserved across all helicase SFs.  Modified from Jackson et al., 2014. 
A
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Twelve characteristic sequence motifs (I, Ia, Ib, Ic, II, III, IV, IVa, V, Va, Vb and VI) 
(Figure 4) are highly conserved across SF2 helicases (Fairman-Williams et al., 2010), 
excluding the Q motif that coordinates ATP binding and hydrolysis (Cordin et al., 2004; 
Tanner et al., 2003).  The helicase core of the SF2 helicase consists of two tandemly repeated 
RecA-like domains, with motifs I, Ia, Ib, Ic, II and III in RecA1 domain and motifs IV, IVa, 
V, Va, Vb, and VI in RecA2 domain (Fairman-Williams et al., 2010; Jackson et al., 2014; 
Jankowsky and Fairman, 2007).  The RecA1 and RecA2 domains each have their conserved 
structural fold in the solved structures of SF2 helicases (Mallam et al., 2012; Sengoku et al., 
2006; Yao et al., 1999).  Motifs I, II, and VI function in ATP binding and hydrolysis; motifs 
III and Va in coordinating nucleic acid binding and ATP binding; motifs Ia, Ib, Ic, IV, IVa, 
V, and Vb function in nucleic acid binding (Fairman-Williams et al., 2010). 
 
Figure 4.  Structural organization of the helicase core of SF2 helicases. 
Position of the characteristic motifs in three-dimensional structures of SF2 protein Vasa 
(Drosophila, PDB: 2DB3).  Characteristic sequence motifs are colored according to their 
predominant biochemical function: red, ATP binding and hydrolysis; yellow, coordination 
between nucleic acid and NTP binding sites; blue, nucleic acid binding.  Modified from 
Fairman-Williams et al., 2010.  
The SF2 helicases are the largest and most diverse of the SF helicases and are further 
divided into ten subfamilies, including DEAD-box, DEAH/RHA, NS3/NPH-II, Rad3/XPD, 
RecGL, RecQL, RIG-I-like, Swi/Snf, Ski2L and type I restriction enzyme families by 
sequence annotation (Fairman-Williams et al., 2010; Jankowsky and Bowers, 2006; 
Jankowsky and Fairman, 2007).  The SF2 helicases are involved in diverse cellular functions 
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chromatin remodeling (Mashtalir et al., 2018) and every step of RNA metabolism from 
transcription to degradation (Kawaoka et al., 2004). Mutations in SF2 helicases underline a 
variety of human genetic (Van Brabant et al., 2000) and inherited diseases (Suhasini and 
Brosh, 2013).  These various diseases can result from the diversities in their additional 
accessory domains at the C or N terminus of the SF2 helicases.  For example, the BLM 
helicase has a RQC (RecQ C-terminal) domain and HRDC (helicase and RNaseD C-terminal) 
domain at its C terminus (Swan et al., 2014). Mutations in BLM helicase cause Bloom 
syndrome, which is characterized by genomic instability with a very high incidence of cancer 
predisposition (Chester et al., 2006; Payne and Hickson, 2009).  XPD helicase has an FeS 
cluster (Rudolf et al., 2006) and an Arch domain (Abdulrahman et al., 2013) at its N terminus. 
XPD is a component of the eukaryotic transcription initiation factor complex TFIIH (Greber 
et al., 2019) that is essential in both transcription initiation and nucleotide excision repair 
(Rudolf et al., 2006; Wolski et al., 2008).  Mutations in XPD helicase are associated with 
three inherited syndromes: Xeroderma pigmentosum, Xeroderma pigmentosum with the 
Cockayne syndrome, and Trichothiodystrophy (Dubaele et al., 2003; Herrera-Moyano et al., 
2014; Suhasini and Brosh, 2013).  The RECQL4 helicase is flanked by an accessory RecQ C-
terminal region that consists of a zinc-finger domain and a winged-helix domain (Mojumdar 
et al., 2017).  Mutations in RECQL4 are associated with Rothmund-Thomson syndrome and 
RAPADILINO syndrome (Lindor et al., 2000; Nishijo et al., 2004; Siitonen et al., 2003; Wang 
et al., 2003).  Finally, the DEAD-box helicase DDX1 has a SPRY domain between the Q 
motif and the N -terminal RecA1-domain (Kellner and Meinhart, 2015).  It was found that 
DDX1 is involved in restricting HIV-1 Rev function in human astrocytes by promoting 
oligomerization of Rev (Edgcomb et al., 2012; Fang et al., 2004, 2005; Robertson-Anderson 
et al., 2011). 
1.4. The DEAD-box helicases 
The DEAD-box helicase is the largest subfamily in the SF2 helicases.  It is called because of 
its characteristic Asp-Glu-Ala-Asp motif within the primary amino acid. These helicases 
contain the DEAD sequence in motif II, as well as eight other conserved sequence motifs, 
including two ATP binding domains (Figure 5).  They are found in a wide range of organisms, 
from viruses to higher eukaryotes.  Importantly, DEAD-box helicases are involved in many 
aspects of RNA metabolism (Bourgeois et al., 2016; Sarkar and Ghosh, 2016), such as 
transcription and pre-mRNA splicing (Honig et al., 2002; Liu, 2002), ribosome biogenesis 
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(Venema and Tollervey, 1999), RNA degradation (Anderson and Parker, 1998; Honig et al., 
2002; Py et al., 1996), and translation initiation (Chuang et al., 1997).  Furthermore, DEAD-
box helicases are implicated in numerous diseases such as the innate immune response against 
pathogens (Ahmad and Hur, 2015), inflammatory disease (Kato et al., 2017), and oncogenesis 
(Bol et al., 2015; Sarkar and Ghosh, 2016). 
 
Figure 5.  Motif structure of DEAD-box helicases. 
DEAD-box helicases are characterized by the presence of an Asp-Glu-Ala-Asp (shown as 
motif II here).  The DEAD-box helicases contain amino-terminal and carboxyl-terminal 
domains (RecA 1 and RecA 2, respectively) and nine characteristic motifs within these 
(depicted in the figure as boxes Q and I–VI).  The known or proposed functions of each motif 
are shown.  Motif II forms interactions with the β-phosphate and γ-phosphate of ATP through 
Mg2+ and is required for ATP hydrolysis.  Modified from Parsyan et al., 2011. 
Mutations in multiple DEAD-box helicase genes are frequently associated with 
diseases and oncogenesis.  For example, mutations within functional domains of DDX41 are 
associated with late-onset hematological myeloid malignancies (Cheah et al., 2017; Polprasert 
et al., 2015; Quesada et al., 2019; Sébert et al., 2019).  Other DEAD-box helicases that have 
been implicated in human malignancies include DDX3 (Bol et al., 2015), DDX5 (Du et al., 
2017), DDX59 (Xie et al., 2019) and DDX17 (Shin et al., 2007).  In addition to germline and 
direct somatic mutations, increased levels of DEAD-box helicases, for example, elF4A1 is 
detected in multiple cancers, indicating a broad role for DEAD-box helicases in tumorigenesis 
(Müller-Tidow et al., 2004).  DDX11 functions at the interface between DNA repair and sister 
I Ia Ib II IV V VI
N C
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chromatid cohesion, and its compromised function is associated with Cohesinopathy in 
Warsaw breakage syndrome as well as Cornelia de Lange and Roberts syndromes (van der 
Lelij et al., 2010).  A hypomorphic pathogenic variant in DDX3X that affects a region of the 
protein outside of the critical RNA helicase domain causes intellectual disability with 
additional neurodevelopmental and neurodegenerative features (Kellaris et al., 2018; Snijders 
Blok et al., 2015).  
1.5. Oral–facial–digital syndromes (OFDS) 
Oral-facial-digital syndromes (OFDS) are rare genetic disorders that affect the development 
of the oral cavity (the mouth and teeth), facial features, and digits (fingers and toes).  OFDS 
has an estimated incidence of one in 50,000 to 250,000, with the majority of the cases being 
OFDS-I (Franco and Thauvin-Robinet, 2016; Thauvin-Robinet et al., 2006).  Researchers 
have identified at least 13 forms of OFDS subtypes (I-XIII) with known causative genes 
(Gurrieri et al., 2007).  The patterns of signs and symptoms distinguish the different subtypes. 
The physical features of various subtypes overlap significantly, and some types are not well 
defined (Table 1).  The signs and symptoms of OFDS vary widely (Chung and Chung, 1999), 
with most types involving a problem with the development of the oral cavity, facial features, 
and digits. Some subtypes are also associated with brain abnormalities and some degree of 
intellectual disability (Erickson and Bodensteiner, 2007). 
Table 1.  Classification of OFDS subtypes by clinical features* 
Locus Gene Inheritance Oral features Facial features Digital 
features 










Cleft lip  

















OFDS III TMEM231 Autosomal 
recessive 
Bifid uvula  
Lingual hamartomas 







OFDS IV TCTN3 Autosomal 
recessive 









































ial polydactyly  
Broad hallux 
OFDS VII - X-linked 
dominant 
Gingival frenulae  






OFDS VIII - X-linked 
recessive 
Gingival frenulae  
Lingual hamartomas 
Lobulated tongue  
Epiglottis hypoplasia 
Midline cleft lip 
Telecanthus Large 
nose 
Bifid thumb  
Preaxial 
polydactyly  




Gingival frenulae  
Lingual hamartomas 
Lobulated tongue  
Cleft palate 






OFDS X - Sporadic Gingival frenulae  
Cleft palate 
Telecanthus  












OFDS XII - Sporadic Gingival frenulae  


































Gingival frenulae  
Lingual hamartomas 

















Midline cleft lips 
Retrognathia 
 


















Lobulated tongue  
Cleft palate 























*Modified and updated from (Bruel et al., 2017; Franco and Thauvin-Robinet, 2016; Gurrieri 
et al., 2007). 
  
 Clinical manifestation of the oral cavity in the different subtypes of OFDS includes a 
split (cleft) in the tongue, a tongue with an irregular surface contour (lobulated tongue), and 
the growth of noncancerous tumors on the tongue (hamartomas).  Affected individuals 
sometimes will display dental irregularities or ceaseless winking of the eyelids (Siebert, 2007; 
Sugarman et al., 1971).  Other known oral features include an opening in the upper lip or roof 
of the mouth (a cleft lip and palate) (Gómez and Puerto, 2017; Mossey et al., 2009), and a 
small fold of extra mucous membrane (hyperplastic frenula) that abnormally attaches the lip 
to the gums (Bhambhani et al., 2015). The clinical facial features often include an opening in 
the upper lip (a cleft lip), a wide-nose with a broad-flat nasal bridge, and wide-spaced eyes 
(hypertelorism) (Bruel et al., 2017).  Skeletal anomalies of the digits include fusion of the 
digits (syndactyly), shorter digits (brachydactyly), unusually curved digits (clinodactyly), or 
the presence of extra digit (polydactyly) as seen in most OFDS (Franco and Thauvin-Robinet, 
2016; Gurrieri et al., 2007).  The most common subtypes of OFDS distinguished from other 
subtypes by associating with a genetic disease.  For example, OFDS-I associate with 
polycystic kidney disease (Donnai et al., 1987; Scolari et al., 1997) that is characterized by 
the growth of multiple cysts within the kidney (Bergmann et al., 2018).  Other subtypes of 
OFDS are associated with neurological abnormalities, particularly affecting the structure of 
the cerebrum (microcephaly), skeletal anomalies (Annerhn et al., 1984), visual impairment, 
and cardiac malformations (Bruel et al., 2017; Franco and Thauvin-Robinet, 2016). 
1.6. Structure and function of cilia 
Cilia are microtubule-based sensory organelles that emanate from the mother centriole and 
protrude from the cell surface.  They are highly conserved throughout evolution and perform 
a wide array of motile and sensory functions (Eggenschwiler and Anderson, 2007).  A 
ubiquitous appearance of the cilia is observed only in vertebrates (Fliegauf et al., 2007).  The 
ciliary structure consists of a basal body, transition zone, and the axoneme (Figure 6). 
Surrounding the ciliary axoneme is the ciliary membrane, which is an extension of the cell’s 
plasma membrane, but separated from this by the ciliary gate (Gilula and Satir, 1972; 
Pedersen and Rosenbaum, 2008) that constitutes a diffusion barrier.  The basal body 
originates from a mother centriole on a centrosome that acts as a microtubule-organizing 
11 
 
center and is an extension of the nine-fold ultrastructure pattern of the centriole (Gonçalves 
and Pelletier, 2017; Nachury et al., 2010).  The transition zone is located at the distal end of 
the basal body (Gonçalves and Pelletier, 2017).  At the transition zone, the triplet microtubules 
of the basal body transition into doublet microtubules to the ciliary membrane (Gonçalves 
and Pelletier, 2017).  Post-translational modifications, such as acetylation, maintain and 
stabilize the microtubule structure (Song and Brady, 2015).  The primary cilia function as 
chemosensory and mechanosensory organelles in addition to cellular signaling pathways 
critical in cellular developmental growth (Irigoin and L. Badano, 2011; Pedersen et al., 2012; 
Zeytinoglu et al., 1996). 
 
Figure 6.  Schematic of primary cilia structure. 
The axoneme is bound by ciliary membrane.  The mother and daughter centrioles are indicated 
by the red cylinders.  The transition zone is also characterized by Y-shaped links that mediate 
interactions with the ciliary membrane.  Transition fibers extend from the distal appendages 
of the mother centriole.  The permeability barrier called the ‘ciliary gate’ is indicated in grey. 
Modified from Malicki and Johnson, 2017. 
There are two groups of cilia, motile or immotile, depending on the location and 
composition of the microtubules.  Motile cilia have a (9+2) design of microtubules surrounded 

























by Y-shaped links characteristics of the transition zone (Gonçalves and Pelletier, 2017).  
Motile cilia are found in a wide range of organisms from the single-celled green algae 
Chlamydomonas reinhardtii to humans, where they can be present in varying numbers per 
cell.  Some motile cilia are responsible for the movement of single cell, such as spermatozoa 
that have one flagellum per cell.  In vertebrates, fluids and particles are transported by motile 
cilia across epithelial surfaces of the respiratory tract, oviducts, and brain ventricles (Enuka 
et al., 2012; Spassky and Meunier, 2017).  The immotile cilia, referred to as primary cilia, 
have a (9+0) design of microtubules in the axonemal structure and lack the central pair of 
microtubules (Berbari et al., 2009).  They lack axonemal dynein and structures that are 
involved in motility.  Primary cilia are mostly present in a single copy per cell when in growth 
arrest.  The primary cilia function to transmit and receive extracellular signals required for 
regulating cellular signaling pathways, such as hedgehog (Hh) and Wnt signaling (Goetz and 
Anderson, 2010; Wallingford and Mitchell, 2011). 
1.7. Ciliary hedgehog signaling 
The Hh pathway was first identified through genetic analysis of Drosophila embryogenesis 
(Nüsslein-volhard and Wieschaus, 1980).  The Hh ligand is a morphogen that functions in a 
concentration gradient manner during tissue development (Mullor and Guerrero, 2000; 
Strigini and Cohen, 1997).  The Hh morphogens are Hh in flies (Nüsslein-volhard and 
Wieschaus, 1980), and Sonic hedgehog (Shh) (Echelard et al., 1993), Indian hedgehog (Ihh) 
(Marigo et al., 1995) and Desert hedgehog (Dhh) (Tate et al., 2000) in mammals.  In 
vertebrates, the Hh signaling regulates cell fate and stem cell maintenance in tissues and 
organs (Ingham and McMahon, 2001; Hooper and Scott, 2005).  Severe developmental 
defects in vertebrates are associated with defective Hh signaling (Bale, 2002; Rohatgi and 
Scott, 2007). 
 The major role of the mammalian Hh pathway involves a sequence of repressions and 
interactions events (Figure 7).  The transmembrane proteins Smoothened (Smo) and patched 
(Ptch1) and the Gli transcription factors are central to the pathway.  Smo is inhibited by Ptch1 
in the absence of a Hh ligand, and is activated in the presence of the Hh ligand (Ingham and 
McMahon, 2001; Rohatgi and Scott, 2007; Wang et al., 2007).  The regulation of Smo leads 
to the transcriptional activation or repression of Hh signaling genes through the Gli 
transcription factors, Gli1-Gli3.  Gli1 and Gli2 function as modified transcriptional activator 
13 
 
GliA, while Gli3 functions in its full length or truncated N-terminal fragment as a repressor  
GliR (Rohatgi and Scott, 2007). 
 
Figure 7.  Basic structure of the mammalian hedgehog pathway. 
In the absence of Hh (left), Gli protein is converted to its repressor form (GliR).  Also, in the 
absence of Hh, Ptch1 is localized to the ciliary membrane, and Smo is kept out of the cilium. 
In the presence of Hh (right), Gli protein levels increase in the cilium and Gli is processed 
into the activator form (GliA) for transport out of the cilium and into the nucleus, where it 
activates Hh target genes.  In the presence of Hh, Ptch1 moves out of the cilium and Smo 
moves into the cilium, where it promotes formation of the activator form of Gli (GliA). Kinesin 
2 moves the intraflagellar transport (IFT) complex and its cargo (e.g., Gli, Ptch, and Smo) 
toward the ciliary tip.  Dynein 2 moves the IFT complex and its cargo toward the cell body. 




































































Ciliogenesis is the process of ciliary formation and occurs in resting cells.  Ciliary formation 
is initiated during cell cycle exit at G1 or G0 phase upon mitogen deprivation or differentiation 
signals, and disassembly takes place upon cell cycle re-entry (Sánchez and Dynlacht, 2016; 
Yoshimura et al., 2007).  Ciliogenesis can be recapitulated in cell lines, such as RPE1 and 
3T3 fibroblasts cells by culturing under serum starvation conditions (Pugacheva et al., 2007; 
Tucker et al., 1979).  Ciliogenesis can be divided into four distinct phases (Figure 8) that 
include all the events that occurred before and after the basal body anchors at the plasma 
membrane. 
 
Figure 8.  Key players and events in cilium formation. 
Cilium formation proceeds through a series of orchestrated and well-defined stages (labelled 
I–IV).  Modified from Sánchez and Dynlacht, 2016. 
The mother centriole transforms into a modified centriole called the basal body, which 
serves as a nucleating site from which the axoneme elongates (Bettencourt-Dias et al., 2011; 
































and accumulation of small cytoplasmic vesicles around the distal appendages of the basal 
body, where they seem to anchor (Kobayashi et al., 2014; Lu et al., 2015; Schmidt et al., 
2012).  These small cytoplasmic vesicles are called distal appendage vesicles, it is assumed 
they originate from the Golgi apparatus and recycling endosomes.  The recruitment and 
accumulation of distal appendage vesicles form a membranous cap called the ciliary vesicle. 
Further anchoring and maturation of the cilium occur by continuous trafficking of ciliary 
vesicles, axonemal and membrane proteins (Sánchez and Dynlacht, 2016). 
The GTPase Rab8a is involved in maturation and trafficking of vesicles to the mother 
centriole (Li and Hu, 2011; Stenmark and Olkkonen, 2001; Yoshimura et al., 2007).  In 
growing cells, Rab8a is localized to cytoplasmic vesicles and the Golgi Network but rapidly 
redistributes to the distal appendages of the mother centriole during ciliogenesis (Li and Hu, 
2011; Westlake et al., 2011; Yoshimura et al., 2007).  After the formation of distal appendage 
vesicles, the Ehd1 protein is recruited (Lu et al., 2015), converting these small vesicles to 
larger and elongating vesicles.  Through continuous fusion with Rab8-positive vesicles, they 
produce the primary cilium membrane (Lu et al., 2015).  Rabin8/Rab11 is responsible for 
activating Rab8 in Rab8-positive vesicles (Westlake et al., 2011), an activation coinciding 
with the activation of the ciliary assembly program. 
The assembly of the distal appendages on the basal body involves the coordinated 
recruitment of five distal appendage proteins (Cep83, Cep89, Cep164, SCLT1, and FBF1) 
(Tanos et al., 2013).  The asymmetric disassembly of CP110 and its interacting partner Cep97 
on mother centrioles may be an obligate event in the initiation of ciliogenesis.  Specifically, 
one distal appendage protein CEP164 has been shown to interact with Rab8a thereby 
mediating anchoring of ciliary vesicles to the distal appendage (Kobayashi et al., 2014; 
Schmidt et al., 2012).  Further, CEP164 recruits TTBK2 and MARK4 kinases required for 
the removal of CP110 from the basal body to trigger ciliogenesis (Čajánek and Nigg, 2014).  
A balance between the activities of PIPKIγ kinase and opposing phosphatase INPP5E 
modulates PtdIns(4)P and PtdIns(4,5)P2 levels (Chávez et al., 2015).  PtdIns(4)P negatively 
regulates the recruitment of TTBK2 by modulating its interaction with Cep164 thereby 
promoting CP110 persistence and suppressing ciliogenesis.  The distal appendages are 
assembly points for the recruitment of IFT proteins and other components required to build 
the cilium and selectively import proteins through the transition zone, which acts as a ciliary 
gate to the cilium (Craft et al., 2015; Lechtreck, 2015). 
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The transition zone is formed after the capping proteins disassembled from the basal 
body.  The cilium is dependent on IFT for assembly, protein transport, and maintenance of 
the axoneme (Craft et al., 2015; He et al., 2017; Jonassen et al., 2008; Stepanek and Pigino, 
2016).  The transportation of proteins is bi-directional (Anterograde and retrograde).  In the 
anterograde, the IFT-B complex associates with the motor protein Kinesin-2 and transports 
proteins along the B tubules towards the cilium tip, while in the retrograde, the IFT-A complex 
associates with Dynein-2 and returns proteins along the A tubules to the cell body (Lechtreck, 
2015; Stepanek and Pigino, 2016).  Further elongation and maintenance of the axoneme after 
the cilium has matured depend on the constant supply of tubulin (Craft et al., 2015). 
1.9. Overlap between OFDS and ciliopathies 
Defects in primary cilia formation or function underlie a range of developmental disorders 
collectively termed ciliopathies.  Ciliopathies are a set of clinically heterogeneous syndromes 
with features that include respiratory complications, renal abnormalities, retinal degeneration, 
structural heart defects, and growth retardation (Hildebrandt et al., 2011).  Examples are 
Bardet-Biedl syndrome (BBS), Senior-Løken syndrome (SLS), Nephronophthisis (NPHP), 
Meckel-Gruber syndrome (MKS), Joubert syndrome (JBTS) and oral facial digital syndrome 
(OFDS).  The understanding of genotype-phenotype correlation to determine ciliopathies is 
complex from a single gene to the effect of multiple allelism (Hildebrandt et al., 2011).  
NPHP5 is mutated in SLS.  NPHP5 interacts with a GTPase regulator and both are localized 
to the connecting cilia of photoreceptors and primary cilia of renal epithelial cells (Otto et al., 
2005).  MKS has extreme genetic heterogeneity and displays allelism with other ciliopathies 
in genes encoding proteins that are structural or functional components of the primary cilium 
(Hartill et al., 2017; Hildebrandt et al., 2011).  Most of the ciliopathies-associated proteins 
localize to the ciliary compartment, and a common molecular etiology of ciliopathies appears 
to be the disruption of ciliary formation and function (Hildebrandt et al., 2011). 
 Like other ciliopathies-associated proteins, the majority of the OFDS-associated 
proteins identified to date localize to ciliary compartments and influence ciliary formation 
and function (Figure 9).  OFD1 contributes to ciliary formation (Ferrante et al., 2006) by 
acting on the distal centriole to build distal appendages (Singla et al., 2010).  Additionally, 
mammalian cells or a mouse model depleted of OFD1 are defective in Shh and Wnt signaling 
(Corbit et al., 2008; Singla et al., 2010).  TCNT3 and TMEMT231 are components of the 
MKS protein complex, and their mutations are implicated respectively in Shh signal 
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transduction (Thomas et al., 2012) and protein localization at the transition zone (Roberson 
et al., 2015).  TMEM216 and TMEM107 are transmembrane proteins localized to the 
transition zone of growing cilia  (Garcia-Gonzalo et al., 2011; Valente et al., 2010) and their 
depletion induced constant deciliation (Gogendeau et al., 2020).  C2CD3 is localized at the 
distal end of the centriole and required for the assembly of distal appendages and ciliary 
vesicles anchoring to the mother centriole (Ye et al., 2014).  The DDX59 gene is the latest 
gene linked to OFDS that affects ciliary function.  Together, there is accumulating evidence 
linking OFDS-associated genes to defects in ciliary formation and function like other 
ciliopathies-associated genes.  The relationship between phenotype and impaired ciliary 
function, and gene function distinct from ciliary function warrants further studies in OFDS 
and ciliopathies (Franco and Thauvin-Robinet, 2016). 
 
Figure 9.  OFDS-associated proteins map to defined primary cilia compartments. 
(A) The localization of proteins encoded by OFDS genes is depicted.  Sixteen OFDS-
associated gene, four genes previously implicated in other ciliopathies (in green) and twelve 
others (white). (B) The precise cilia localization is defined. Whether Ciliary formation or Shh 
signaling defect is demonstrated (+) or not known (NK).  Modified and updated from Bruel et 



























Gene Localization Cilia/Shh References
C2CD3 Centrosome, 
transition fiber
+/+ Hoover et al., 
2008
C5orf42 Basal body, 
transition zone




NK/+ Shamseldin et 
al., 2013
IFT57 Basal body, 
Axoneme
+/+ Thevenon et al., 
2016
INTU Basal body +/+ Toriyama et al., 
2016
KIAA0753 Centrosome +/+ Chevrier et al., 
2015
NEK1 Centrosome +/+ Monroe et al., 
2016
OFD1 Centrosome +/+ Ferrante et al., 
2001
SCLT1 Centrosome +/NK Adly et al.,2013
TBC1D32 Centrosome +/+ Adly et al.,2013
TCTN3 Transition 
zone








+/+ Li et al., 2016
TMEM216 Transition 
zone




+/+ Li et al., 2016
WDPCP Basal body, 
transition zone






1.10. DDX59 as a causative OFDS gene 
The DDX59 gene encodes a relatively uncharacterized member of the DEAD-box helicase 
protein family (Figure 10).  By exome sequencing, mutations in DDX59 were found to be 
associated with OFDS in 2013 (Shamseldin et al., 2013). In developing mouse embryos, 
DDX59 expression is seen in secondary palate, lip, snout region, eye, and limb buds’ tissues 
(Faily et al., 2017; Salpietro et al., 2018; Shamseldin et al., 2013).  Patient fibroblast cells 
from a skin biopsy with DDX59 mutation (V367G) showed normal nuclear and cytoplasmic 
localization with significantly reduce protein level of DDX59, and normal ciliation with 
significantly reduced Shh signaling (Shamseldin et al., 2013).  A report on a homozygous 
frameshift deletion in DDX59 (F62fs*13) in a family presenting with an OFDS phenotype 
showed a reduction of mutant cDNA and perturbation of Shh signaling in patient-derived cell 
lines (Salpietro et al., 2018).  However, the exact functions of DDX59 helicase in ciliogenesis 
and the pathogenesis of OFDS are unclear. 
 
Figure 10.  Schematic representation of DDX59 helicase and its primary protein 
sequence. 
Conserved sequence motifs are highlighted in yellow boxes, the zinc finger HIT domain in 











AKRVKPTGSILPPQLLNSPYLHDQKRKEQQKDKQTQNDLVTGANLMDIIRKHDKSNSQK            619
















2. HYPOTHESIS AND OBJECTIVES  
2.1. Rational and Hypothesis 
Although DDX59 belongs to the DEAD-box helicase family, the unwinding activity is 
undescribed experimentally.  We hypothesize that DDX59 is a novel RNA or DNA helicase, 
and defects in its biochemical activities cause OFDS. 
2.2. Objectives 
2.2.1. To biochemically characterize DDX59 protein activities and examine the effect of 
OFDS DDX59 mutations. 


















3. MATERIALS AND METHODS 
3.1. Reagents and antibodies 
Table 2.  List of reagents used in this study 
Reagents Suppliers Address 
2-logDNA ladder, N3200L NEB Lawrenceville, Georgia, USA 
Acrylamide, 0314 AMRESCO North York, Ontario, Canada 
N,N'-Methylenebisacrylamide, 
AC164790250hrp 
Fisher Scientific Madison, Wisconsin, USA 
Adenosine Triphosphate (ATP), 
A1852 
Sigma-Aldrich Oakville, Ontario, Canada 
 
Adenosine Diphosphate (ADP), 
A2754 









Enzolifesciences Brockville, Ontario, Canada 
Agarose, 5510UB Gibco Burlington, Ontario, Canada 
Ampicillin, A1593 Sigma-Aldrich Oakville, Ontario, Canada 
Ammonium persulfate (APS), 
A3678 
Sigma-Aldrich Oakville, Ontario, Canada 
Boric Acid, SLBC5554V Sigma-Aldrich Oakville, Ontario, Canada 
Bovine serum albumin (BSA), 
A2058 
Sigma-Aldrich Oakville, Ontario, Canada 
Bradford protein assay reagent, 
500-0013 
Bio-Rad Hercules, California, USA 
Bromophenol blue, B0126 Sigma-Aldrich Oakville, Ontario, Canada 
Chloramphenicol, 
AC227920250 
Fisher Scientific Madison, Wisconsin, USA 
Dithiothreitol (DDT), 
10197777001 
Sigma-Aldrich Oakville, Ontario, Canada 
dNTPs, N0447S NEB Mississauga, Ontario, Canada 
Dulbecco's Modified Eagle 
Medium (DMEM), SH30022.01 




Fisher Scientific Madison, Wisconsin, USA 
Fetal Bovine Serum (FBS), 
F6178 
Sigma-Aldrich Oakville, Ontario, Canada 
Formic Acid, F0507 Sigma-Aldrich Oakville, Ontario, Canada 
Glycine, BP381-5 Fisher Scientific Madison, Wisconsin, USA 




Sigma-Aldrich Oakville, Ontario, Canada 






Fisher Scientific Madison, Wisconsin, USA 
Kanamycin, 60615 Fisher Scientific Madison, Wisconsin, USA 
Lithium chloride (LiCl) Fisher Scientific Madison, Wisconsin, USA 
Lysogeny Broth (LB) with agar, 
L2897 
Sigma-Aldrich Oakville, Ontario, Canada 
Methanol, 154246 Sigma-Aldrich Oakville, Ontario, Canada 
Magnesium Chloride (MgCl2), 
M8266 
Sigma-Aldrich Oakville, Ontario, Canada 
Magnesium sulfate (MgSO4), 
M2643 




Sigma-Aldrich Oakville, Ontario, Canada 
Nickel-NTA Affinity beads, 
70666 
Sigma-Aldrich Oakville, Ontario, Canada 
Non-fat dry milk, 170-6404 Sigma-Aldrich Oakville, Ontario, Canada 








Sigma-Aldrich Oakville, Ontario, Canada 
Phenylmethylsulfonyl fluoride 
(PMSF), P7626 
Sigma-Aldrich Oakville, Ontario, Canada 
Protein standard, 161-0374 Bio-Rad Hercules, California, USA 
Protease inhibitor, 05892791001 Roche Mannheim, Germany 
Polyvinylidene difluoride 
(PVDF), 10600023 
GE healthcare Mississauga, Ontario, Canada 
Sodium dodecyl sulfate (SDS), 
L3771 
Sigma-Aldrich Oakville, Ontario, Canada 
Sodium chloride (NaCl), S671-
10 
Fisher Scientific Madison, Wisconsin, USA 
T4 DNA Ligase, M0202S NEB Lawrenceville, Georgia, USA 
T4 polynucleotide kinase, 
M0201S 
NEB Mississauga, Ontario, Canada 
Tris, 0826 AMRESCO North York, Ontario, Canada 
Tris(2-carboxyethyl) phosphine, 
C4706 
Sigma-Aldrich Oakville, Ontario, Canada 
Triton-X100, T8787 Sigma-Aldrich Oakville, Ontario, Canada 
Trypsin-EDTA, T4049 Sigma-Aldrich Oakville, Ontario, Canada 
Trypsin, 85450C Sigma-Aldrich Oakville, Ontario, Canada 
Tryptone, TRP402.205 BioShop Burlington, Ontario, Canada 
TWEEN®20, BP337 Fisher Scientific Madison, Wisconsin, USA 
Q5®Hot Start High-Fidelity 
DNA Polymerase, M0493S 
NEB Mississauga, Ontario, Canada 
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Western Blotting detection 
reagent, RPN2232 
GE Health care Little Chalfont, UK 
Xylene cyanol, X4126 Sigma-Aldrich Oakville, Ontario, Canada 
Mouse anti-β-actin (AC-15), 
A5441 
Sigma Aldrich Oakville, Ontario, Canada 




Madison, Wisconsin, USA 




Madison, Wisconsin, USA 
Mouse anti-DDX59, 514439 Santa Cruz Dallas, Texas, USA 
 
 
Table 3.  Oligonucleotides used for CRISPR, cloning, and mutagenesis 
Primer Sequence (5'-3') Used in this study 
DDX59-sgRNA-4T CACCGGCACAGTTTTCATGC
GTGGC 







Forward primer to PCR 
amplify the genomic DNA 




Reverse primer to PCR 
amplify the genomic DNA 




Forward primer to PCR 
amplify the full-length 
DDX59 gene, with cloning 
site Nde I for pET28a vector 
DDX59-XhoI-R CATGCTCGAGTTTCTGAGAA
TTACTTTTATCATG 
Reverse primer to PCR 
amplify the full-length 
DDX59 gene, with cloning 
site Xho I for pET28a vector 
DDX59_V367G_F GTTTTCAACAACAAGGGCTT
GACATTTTGGA 











































































Fork 30/15-T: TTTTTTTTTTTTTTTGGTGATG 
GTGTATTGAGTGGGATGCATGCA 






















































3.2. Plasmid DNA and mutagenesis 
The human DDX59 gene was PCR amplified from the universal human cDNA (636753, 
Clontech) using primers DDX59-F-NdeI and DDX59-R-XhoI (Table 3) and cloned into the 
NdeI and XhoI sites of the His-tagged pET28a vector (Novagen) for bacterial expression.  
The V367G and G534R mutations were generated by a QuikChange site-directed mutagenesis 
kit (Stratagene) according to the manufacturer's instructions using the designed mutagenic 
primers (Table 3).  All plasmids were sequenced to ensure the fidelity of all constructs. 
3.3. Cell culture 
RPE-1 cells (gift from Dr. Laurence Pelletier, the Lunenfeld-Tanenbaum Research Institute, 
Mount Sinai Hospital, Toronto) were cultured in DMEM F12 or DMEM with 10% FBS, 
100 U/mL penicillin/streptomycin, 0.01 mg/mL hygromycin B under 5% CO2 at 37°C. 
3.4. Expression and purification of DDX59 recombinant proteins 
The plasmid pET28a-His-tagged-DDX59 was transformed into E. coli Rosetta 2 cells (EMD 
Millipore). The Rosetta 2 cells were cultured in LB medium containing 50 μg/mL kanamycin 
and 34 μg/mL of chloramphenicol and incubated at 37°C until the OD600 reached 0.4.  Protein 
expression was induced by adding 0.3 mM IPTG to the culture and incubated overnight at 
16°C.  The culture was harvested by centrifugation at 6,000 g for 10 min at 4°C.  The removal 
of periplasmic material from the cells was followed using the method described in 
Magnusdottir et al., 2009.  Briefly, the cells were suspended in 5 mL/g of cell mass of 
hypertonic buffer solution (50 mM HEPES, pH 7.4, 20% sucrose, 1 mM EDTA) and 
centrifuged at 7,000 g for 10 min at 4°C.  The cells were re-suspended in 5 mL/g of cell mass 
of hypotonic solution (5 mM MgSO4) and incubated for 10 min on ice.  Cells were then 
pelleted by centrifugation at 5000 g for 10 min at 4°C and stored at -80°C until used.  The 
cell suspension was lysed by sonication in buffer A (50 mM HEPES, pH 7.4, 0.15 M NaCl, 
0.01% Tween-20 and 10% glycerol) having a final concentration of 10 mM 
phenylmethylsulfonyl fluoride (PMSF) and protease inhibitor (Roche Applied Science), at 
4°C, with five short bursts of 10 sec at intervals of 5 min.  The cell debris and inclusion bodies 
were removed by centrifugation at 45,000 g for 30 min at 4°C.  Recombinant proteins were 
subjected to a two-step purification using Nickel Affinity beads (Sigma) and a Sephacryl S-
300 HR 16/60 gel filtration column (GE Healthcare).  The supernatant was applied to the Ni-
NTA beads equilibrated with buffer A; washed with 10 column volumes (CV) of buffer B (50 
mM HEPES, pH 7.4, 0.3 M NaCl, 0.01% Tween-20 and 10% glycerol) containing 25 mM 
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imidazole and eluted with five CV of buffer B containing 250 mM imidazole.  The protein 
fractions were analyzed on reducing SDS-PAGE stained with Coomassie brilliant blue; the 
fractions containing high protein yield were combined and subjected to size-exclusion 
chromatography on a Sephacryl S-300 HR 16/60 (GE Healthcare) equilibrated with buffer A.  
The fractions were collected at a flow rate of 1 mL/min using buffer A.  The purity of four 
protein fractions that eluted in peak 2 of the size-exclusion chromatogram were confirmed on 
a reducing SDS-PAGE stained with Coomassie brilliant blue and by Western blotting.  The 
protein fractions were pooled and concentrated.  The purified protein fractions were snapped 
frozen in liquid nitrogen and stored at - 80°C until use.  The protein concentration was 
determined using the Bradford method with bovine serum albumin (BSA) used as standard 
protein concentration. 
3.5. Preparation of DNA and RNA substrates 
PAGE-purified oligonucleotides were purchased from Integrated DNA Technologies and are 
listed in Table 4.  The double-stranded DNA and RNA substrates were prepared as described 
in (Talwar et al., 2017).  Single stranded DNA or RNA oligonucleotides were labeled at the 
5′-end with using T4 polynucleotide kinase (NEB) in the presence of [γ-32P]-ATP at 37°C for 
1 h.  The 5′-end [γ-32P]-labeled single stranded DNA or RNA oligonucleotides were purified 
using G25 chromatography column (GE Healthcare) and kept at 4°C until use.  Annealing of 
the 5′-end [γ-32P]-labeled single stranded DNA or RNA oligonucleotides with 2.5 fold molar 
excess unlabeled complementary strand was done in annealing buffer (10 mM Tris–HCl, pH 
7.5, 50 mM NaCl for DNA or 10 mM MOPS, pH 6.5, 1 mM EDTA, 50 mM KCl for RNA) 
by heating at 95°C for 6 min and then gradually cooling to room temperature.  Annealed 5′-
end [γ-32P]-labeled double-stranded DNA or RNA substrates were purified by PAGE 
isolation.  The final concentration of the annealed 5′-end [γ-32P]-labeled double-stranded 
DNA or RNA substrate was estimated before use by liquid scintillation counting. 
3.6. Helicase assays 
The helicase assays were done as described in Talwar et al., 2017.  Briefly, the helicase assay 
reactions were done in a 20 μL mixture containing 40 mM Tris (pH 8.0), 0.5 mM MgCl2, 0.15 
mM NaCl, 0.01% Nonidet P-40, 0.1 mM DTT, 1 mg/mL BSA, 2 mM ATP, 2mM MgCl2, 0.5 
nM of the specified double-stranded RNA or DNA substrate with the indicated concentrations 
of DDX59 protein.  DDX59 proteins were added to initiate the reaction at 37°C for 30 min or 
indicated time.  20 μL of 2×stop buffer (17.5 mM EDTA, 0.3% SDS, 12.5% glycerol, 0.02% 
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bromophenol blue, 0.02% xylene cyanol) containing a 10-fold molar excess of unlabeled 
oligonucleotide of the 5′-end [γ-32P]-labeled single stranded DNA or RNA oligonucleotide 
was used to quench the reactions.  Helicase assay reactions containing RNA substrates were 
resolved on non-denaturing 15% (19:1 acrylamide: bisacrylamide) polyacrylamide gels while 
DNA substrates were resolved on non-denaturing 12% (19:1 acrylamide: bisacrylamide) 
polyacrylamide gels.  All reactions were resolved on the gels for 2 h at 180 V.  The results of 
the helicase assay reactions were visualized using a Phosphor Imager and quantitated using 
Quantity One software (Bio-Rad). 
3.7. Strand annealing assays 
The strand annealing assays were done as described in Talwar et al., 2017.  The reaction (20 
µL) was carried out with 0.5 nM of radiolabeled 13 bp double-stranded RNA.  The substrate 
was denatured first at 100°C for 5 min and then incubated with 0 to 300nM of DDX59 protein 
at 37oC for 30 min with or without 2 mM ATP.  The reaction was quenched by adding an 
equal volume of 2×stop buffer (17.5 mM EDTA, 0.3% SDS, 12.5% glycerol, 0.02% 
bromophenol blue, 0.02% xylene cyanol).  The mixture was resolved on a 15% native PAGE 
gel for 2 h at 180 V.  The strand annealing assay reactions were visualized using a Phosphor-
Imager (Bio-Rad) and analyzed using Quantity One software (Bio-Rad). 
3.8. Electrophoretic mobility shift assay (EMSA) 
Protein-RNA binding mixtures (20 µL) contained the indicated concentrations of DDX59 and 
0.5 nM of the specified 32P-end-labeled RNA substrate in the helicase assay reaction buffer 
(see above) without ATP.  The binding mixtures were incubated at room temperature for 30 
min after adding DDX59.  After incubation, 3 µL of loading dye (74% glycerol, 0.01% xylene 
cyanol, 0.01% bromophenol blue) was added to each mixture, and samples were loaded onto 
native 5% (19:1 acrylamide/bisacrylamide) polyacrylamide gels and electrophoresed at 180 
V for 2 h at 4°C using 1×TBE as the running buffer.  The EMSA reactions were visualized 








3.9. CRISPR/Cas9 knockout of DDX59 gene 
For genome targeting, DDX59-sgRNA-4T (Table 3) was designed using the online software 
http://crispr.mit.edu/.  Annealed oligos were cloned into th Bbs1 sites of the pSpCas9(BB)-
2A-Puro (pX459) vector (#62988, Addgene).  The constructs were transiently transfected into 
RPE1 cells using Lipofectamine 3000 (Invitrogen).  24 h after transfection, puromycin 
(5 μg/mL) was added into the medium for selection for 14 days.  The clones were picked 
individually and grown in six well plates until confluency, with the cells lysed using RIPA 
buffer (25 mM Tris, pH 7.4; 150 mM NaCl; 0.5% sodium deoxycholate; 1% NP-40) with 2 
mM phenylmethylsulfonyl fluoride (PMSF) and protease inhibitor cocktail (Sigma).  Gene 
knockout was confirmed by Western blot analysis using an anti-DDX59 antibody (#514439, 
Santa Cruz).  Genomic DNA of RPE1 cells was isolated by phenol–chloroform extraction. 
The targeted region was PCR amplified using primers DDX59-sgRNA-gF and DDX59-
sgRNA-gR for sgRNA-4 (Table 3).  The PCR products were then cloned into the TOPO-TA 
vector (Invitrogen) for sequencing. 
3.10. Western blotting 
Protein concentrations were determined with the Bio-Rad DC protein assay kit (Bio-Rad) 
using BSA as a standard.  Protein samples were reduced by heating at 95°C for 5 min in SDS 
sample buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.002% bromophenol blue 
and 0.0625 M Tris HCl, pH 6.8), and the proteins were separated on a 10% SDS-PAGE gel 
under reducing condition at 120 V for 90 min.  For Western blotting, proteins were transferred 
onto nitrocellulose membranes (Bio-Rad) at 35 V for 16 h at 4°C.  After blocking in PBS-T 
containing 5% nonfat milk for 1 h at room temperature, the membranes were washed in PBS-
T and incubated overnight with the appropriate primary antibodies at 4°C.  Subsequently, the 
membranes were washed with PBS-T, and incubated with the appropriate secondary 
antibodies for 2 h.  The membranes were washed in PBS-T and the bands were developed 
using Chemiluminescent detection using a ChemiDoc MP Imaging System (Bio-Rad). 
3.11. Immunofluorescence 
Cells were grown to confluence and washed twice with PBS and fixed with 4% 
paraformaldehyde for 15 min at room temperature.  Fixed cells were washed with PBS then 
blocked with blocking buffer (1% BSA in PBS) at room temperature for 1 h.  The cells were 
washed in PBS, and immunostaining was performed by first incubating cells with a mouse 
anti-acetyl-α tubulin (1:500, 6-11B-1, Invitrogen) overnight at 4°C.  After washing with PBS, 
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the cells were incubated with Alexa Fluor 488 goat anti-mouse IgG (1:1000, Invitrogen) for 
1 h at room temperature.  Cells were then washed with PBS and mounted with Prolong 
Diamond antifade reagent containing DAPI (Invitrogen), and cured at room temperature in 
the dark for 24 h.  Immunofluorescence was performed on a Zeiss LSM 510 META inverted 
Axiovert 200 M laser scan microscope with a Plan-Apochromat 63×/1.4 oil DIC objective.  
Images were captured with a CCD camera and analyzed using the LSM Browser software 
ZEN (Zeiss). 
3.12. Statistical analysis 
All statistical analyses were performed in Microsoft Excel.  Results are reported as mean ± s.d. 
of at least three independent experiments.  Comparisons were analyzed using one-way 

























4.1. Expression and purification of recombinant DDX59 proteins 
We overexpressed the recombinant DDX59 protein in Rosetta 2 E. coli, and optimized the 
purification using Nickel affinity and size exclusion chromatography (Figure 11).  The 
recombinant 6xHis-DDX59 protein was purified in the first step at the expected molecular 
weight of 70 kDa (Figure 11A, black arrow).  However, an unknown protein band (Figure 
11A, red arrow) appeared just below the DDX59 protein, which might affect subsequent 
enzymatic assays.  To obtain our target protein and exclude the unwanted protein(s), we then 
pooled fractions 6, 7 and 8 from the nickel purified fractions (Figure 11A) and proceeded 
with size exclusion chromatography to separate the proteins based on size.  It resulted in two 
peaks: one in the void volume (Peak 1) and the other containing DDX59 protein at the 
expected molecular weight (Peak 2) (Figure 11B).  Fractions from peak 2 were further 
analyzed for purity on a SDS PAGE-Coomassie stained gel (Figure 11C).  The DDX59 
protein identity was determined by Western blotting using anti-DDX59 and anti-His 
antibodies, respectively (Figure 11 D and E).  These results show that we were able to 





Figure 11.  Purification and identification of recombinant DDX59 protein. 
(A) A 10% polyacrylamide Coomassie stained gel showing fractions from nickel affinity 
purification.  Recombinant 6xHIS-DDX59 and an unexpected protein are indicated with black 
and red arrows respectively.  M is the protein molecular weight markers. 4-12 are fraction 
number.  (B) Size exclusion chromatography profile of recombinant 6xHIS-DDX59 protein. 
(C) A 10% polyacrylamide Coomassie stained gel showing four fractions from Peak 2 in B. 
(D and E) Four fractions shown in Figure 11C were analyzed by Western blotting using anti-




















































4.2. DDX59 is ineffective as RNA helicase in vitro 
DDX59 is predicted to be a DEAD-box RNA helicase by sequence homology (Shamseldin et 
al., 2013).  To characterize the RNA unwinding activity, we used 5′- (Figure 12A) and 3′-
tailed (Figure 12B) 13-bp double-stranded RNA substrates in helicase assays.  We found that 
DDX59 could not effectively unwind these RNA substrates compared to DDX43 which 
effectively unwound the double-stranded RNA as previously reported (Talwar et al., 2017).  
Although we observed a residual unwinding activity with the 3′-tailed 13-bp double-stranded 
RNA, this activity did not increase with increasing protein concentration (Figure 12C).  
Therefore, we could not show an effective RNA helicase activity for DDX59 protein. 
We then asked whether the absence of helicase unwinding activity is due to strong 
strand annealing activity observed in some helicases (Wu, 2012).  We performed strand 
annealing assays by using the two complementary strands of the 3′-tailed 13-bp double-
stranded RNA in the presence and absence of ATP.  However, we did not observe any 
annealing activity in forming the RNA double strand in the absence or presence of ATP 
(Figure 12D). 
We hypothesized that the absence of effective unwinding and annealing activity is due 
to the inability of DDX59 to bind the substrates.  To address this, we performed EMSA and 
found that DDX59 did not bind the 3′- (Figure 12E) or 5′-tailed (Figure 12F) 13-bp double-




Figure 12.  DDX59 does not unwind RNA substrates effectively. 
(A and B) Representative 15% polyacrylamide gel showing the helicase activity of DDX59 
performed by incubating 0.5 nM 5′-tailed (A) and 3′-tailed (B) 13-bp double-stranded RNA 
substrate at increasing DDX59 protein concentration (0-30 nM) at 37°C for 30 min.  DDX43 
protein (300 nM) was used as a positive control.  (C) Quantification of helicase activity shown 
in Figure 12A and B.  (D) Representative 15% polyacrylamide gel showing the annealing 
activity of DDX59 performed by incubating 0.5 nM each of complementary strands of 3′-
tailed 13-bp double-stranded RNA substrate at increasing DDX59 protein concentration (0-
30 nM) at 37°C for 30 min.  (E and F) Representative 5% polyacrylamide gel showing the 
binding of DDX59 performed by incubating 0.5 nM of 3′-tailed (E) or 5′-tailed (F) 13-bp 
double-stranded RNA substrate at increasing DDX59 protein concentration (0-30 nM) on ice 
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4.3. DDX59 is a 3′→5′ DNA helicase 
We next asked whether DDX59 possesses DNA unwinding activity.  We employed a 19-bp 
forked double-stranded DNA substrate that has single-stranded DNA at both 5′ and 3′ tails.  
We found that DDX59 could efficiently unwind the 19-bp forked double-stranded DNA 
substrate in the presence of ATP in a time- (Figure 13A) as well as a concentration-dependent 
manner (Figure 13B).  To define the loading strand and directionality required for DDX59 to 
initiate DNA unwinding, we used a 3′-tailed (Figure 13C), 5′-tailed (Figure 13D) and blunt-
end (Figure 13E) 19-bp double-stranded DNA substrates and found that DDX59 unwound 
the 3′-tailed double-stranded DNA substrate effectively, but not the 5′-tailed or the blunt-end 
double-stranded DNA substrate.  Collectively, these findings demonstrated that DDX59 is a 
3′→5′ DNA helicase. 
Next, we examined the DNA helicase activity on variable lengths of double-stranded 
DNA substrates.  For this we used three DNA substrates where the loading strand is kept 
constant (15 nt) and the length of the double strand is increased progressively from 30 bp, 40 
bp to 50 bp (Talwar et al., 2017).  DDX59 was able to unwind all substrates (Figure 13 F, G 
and H); however, the unwinding activity for the 40 bp is more effective than the 30 bp and 
50 bp substrates, and the unwinding of the 30 bp is less effective than the 50 bp (Figure 13I).  
The discrepancy of these unexpected helicase unwinding activities is due to the difference in 
the nucleotide sequence composition which might reflect the varied stability of the double-




Figure 13.  DDX59 shows DNA helicase activity. 
(A) Representative 12% polyacrylamide gel showing the helicase activity of DDX59 
performed by incubating 0.5 nM 19-bp forked double-stranded DNA substrate with 150 nM 
DDX59 protein at 37°C for the indicated time.  (B-E) Representative 12% polyacrylamide 
gel showing the helicase activity of DDX59 performed by incubating 0.5 nM 19-bp forked 
(B), 3′-tailed (C), 5′-tailed (D), blunt-end (E) 19 bp double-stranded DNA substrates at 
increasing DDX59 protein concentration (0-300 nM) at 37°C for 30 min.  (F-H) 
Representative 12% polyacrylamide gel showing the helicase activity of DDX59 performed 
by incubating 0.5 nM 30-bp (F), 40-bp (G), and 50-bp (H) forked double-stranded DNA 
substrate at increasing DDX59 protein concentration (0–300 nM) at 37°C for 30 min.  NE 
represents no enzyme control and ▲ represents 95°C heated substrate.  (I) Quantification of 
























































































4.4.  ATP hydrolysis is required for DDX59 unwinding activity 
Helicases employ the energy resulting from the ATP hydrolysis cycle to unwind a nucleic 
acid double strand (Dehghani-Tafti et al., 2019; Wiegand et al., 2019).  To determine the NTP 
required for optimal DDX59 DNA helicase unwinding activity, we employed a standard in 
vitro helicase assay.  We found that DDX59 unwound the DNA substrate in the presence of 
ATP or dATP (Figure 14A). 
 Next, we examined whether DDX59 could unwind a double-stranded DNA substrate 
with the non-hydrolysable ATP analogs ATP-γS or AMP-PNP.  As expected, no unwinding 
activity was observed with ATP-γS and AMP-PNP compared to the ATP control (Figure 
14B).  Repeated release of an unwound substrate and helicase recycling is critical for efficient 
nucleic acid double strand unwinding (Wiegand et al., 2019).  To mimic a single reaction 
turnover condition, we used the non-hydrolysable ATP analog ADP-BeFx extensively used 
in mechanistic and structural studies of other helicases (Chen et al., 2007; Fisher et al., 1995; 
Kagawa et al., 2004; Liu et al., 2008a).  As expected, no unwinding activity was observed 
with the ADP-BeFx compared to the ATP control (Figure 14C).  These results demonstrated 




Figure 14.  ATP hydrolysis is required for DDX59 unwinding activity. 
(A) Representative 12% polyacrylamide gel showing the helicase activity of DDX59 
performed by incubating 0.5 nM forked 19-bp double-stranded DNA substrate with 150 nM 
DDX59 protein at 37oC for 30 min with various nucleoside triphosphates (2 mM).  (B) 
Representative 12% polyacrylamide gel showing the helicase activity of DDX59 performed 
by incubating 0.5 nM of forked 19-bp double-stranded DNA substrate with ATP or ATP 
analogs at increasing DDX59 protein concentration (0–300 nM).  (C) Representative 12% 
polyacrylamide gel showing the helicase activity of DDX59 performed by incubating 0.5 nM 
of 19 bp forked double-stranded DNA substrate at increasing DDX59 protein concentration 
(0–300 nM) and 2 mM of ATP or ADP-BeFx at 37oC for 30min.  NE represents no enzyme 














































































4.5. DDX59 is necessary for the formation of primary cilia 
Most of the OFDS-associated genes identified to date localize to the ciliary compartments 
and affect the function and formation of primary cilia (Bruel et al., 2017; Franco and Thauvin-
Robinet, 2016).  Thus, we asked whether DDX59 is involved in the formation of primary 
cilia.  To address this, we generated a DDX59-knockout RPE1 cell line using the CRISPR-
Cas9 system.  The RPE1 cell line is commonly used for cilia studies because they form cilia 
efficiently and the length of cilia formed is uniform (Spalluto et al., 2013).  Upon Western 
blotting analysis from a whole cell lysate, we found endogenous DDX59 expression disrupted 
in two clones (Figure 15A).  The selected DDX59-knockout clones were further analyzed for 
insertion or deletion by TA cloning of genomic PCR products.  DNA sequencing revealed 
that the selected clones were heterozygous, one allele was wild-type, the other had 14 
nucleotides deletion, or a single nucleotide insertion (Figure 15B).  We again attempted to 
obtain a DDX59-homozygous knockout cell line, by repeating transfection, using more serial 
dilution for the survived cells, or using another cell line (A549), but without success.  
Importantly we detected a low survival rate (about 40-60%) in the subsequent culture of the 
DDX59-knockout RPE1 cells after puromycin selection, indicating that DDX59 is essential 
for the survival of RPE1 cells.  A similar observation has been reported in other cell lines 
(HAP1 and KBM7) (Blomen et al., 2015; Yilmaz et al., 2018).  Mahe, the Drosophila 
homolog of DDX59, is essential for survival as well (Salpietro et al., 2018).  Importantly, the 
first three passages of DDX59-depleted RPE1 cells had minimal consequences on viability, 
providing an opportunity window to investigate DDX59 function on ciliary formation. 
 Following confirmation of the successful depletion of DDX59 in RPE1 cell lines, we 
proceeded to investigate the impact of DDX59 on the formation of primary cilia.  We 
visualized the formation of primary cilia by immunofluorescence using an antibody against 
acetylated α-tubulin, generally considered as a primary ciliary marker (Satir and Christensen, 
2007; Shamseldin et al., 2013).  We observed a remarkable reduction (about 4-fold) in the 
number of ciliated cells in the DDX59-heterozygous knockout cell line, compared to the wild 
type cell line (Figure 15 C and D).  These results indicate that DDX59 is necessary for the 




Figure 15.  Depletion of DDX59 affects the formation of primary cilia. 
(A) Level of endogenous DDX59 protein in whole cell lysate was detected by Western 
blotting analysis using a DDX59 antibody.  β-actin antibody serves as a loading control.  (B) 
Alignment of DNA sequences of the two DDX59-heterozygous knockout RPE1 cell lines 
indicates insertion or deletion in one allele (red arrow).  The PAM and target sequences are 
indicated.  (C) The indicated vector control and DDX59-heterozygous knockout RPE1 cell 
lines were immunostained for primary cilia using an acetylated-α-tubulin antibody.  The 
nucleus was stained using DAPI.  (D) Quantification of experiments shown in Figure 15C.  
One hundred cells for each sample were counted.  P value was determined by one-way 































































































4.6. DDX59 OFDS mutants have reduced helicase activity 
Only four recurrent DDX59 variants have been reported in OFDS patients (Figure 16A) 
(Faily et al., 2017; Salpietro et al., 2018; Shamseldin et al., 2013).  The frame shift F62fs*13 
yields a truncated DDX59 protein devoid of most predicted sequence motifs, and the 
*620fs*22 extends the full-length DDX59 protein by 22 amino acids likely affecting helicase 
function.  Therefore, in this study, we focused on the two missense mutations notably, these 
residues are conserved from chicken to humans, V367G and G534R (Figure 16B). 
 To determine the effect of these missense mutations on the DNA unwinding activity 
of DDX59, we purified these two mutant proteins (Figure 16C) and performed in vitro DNA 
helicase assays using a 19-bp forked double-stranded DNA substrate (Figure 16D).  Only 
reduced unwinding activity was observed for the V367G and G534R proteins, when 
compared to the wild-type protein (Figure 16E).  These results suggest that the OFDS 




Figure 16.  DDX59 mutations in OFDS disrupt the helicase unwinding activity. 
(A) Schematic depiction of the wild-type and mutant DDX59 proteins containing individual 
DDX59 mutations identified in OFDS.  Vertical lines (Red) denote sites of individual 
missense and frame shift mutations.  (B) Evolutionary conservation of the mutated amino 
acids in DDX59.  The conservation is also represented in different shades of gold with 
numbers below each amino acid indicating the degree of identity from the lowest (1) to the 
highest (*).  The DDX59 mutations identified in OFDS are highlighted in red.  (C) A 10% 
polyacrylamide Coomassie stained gel showing purified recombinant DDX59 OFDS mutant 
proteins.  (D) Representative 12% polyacrylamide gel showing the helicase activity of 
DDX59 proteins performed by incubating 0.5 nM of fork 19bp double-stranded DNA 
substrate at increasing protein concentration (0-300 nM) at 37°C for 30 min.  NE represents 
no enzyme control and ▲ represents 95oC heated substrate.  (E) Quantification of helicase 





























































In this study, we showed that DDX59 is an ATP-dependent DNA helicase and not an effective 
RNA helicase.  DDX59 accomplishes this task by loading on the 3'-overhang of single-
stranded DNA.  We showed that DDX59 is essential for ciliary formation. We provided 
biochemical evidence that OFDS-associated DDX59 missense mutations are defective in 
DDX59 DNA helicase.  Collectively, we uncovered the significance of DDX59 in the 
potential pathogenesis of OFDS, supporting the notion that OFDS is one of the ciliopathies. 
5.1. DDX59 is a 3′→5′ ATP-dependent DNA helicase, and ineffective as 
RNA helicase 
Our findings that DDX59 acts as a helicase on double-stranded DNA provide additional 
insight into the function of DEAD-box helicases in DNA metabolism.  DEAD-box helicases 
display unwinding activities on RNA (Jarmoskaite and Russell, 2011) and some having 
activities on DNA as well (Kikuma et al., 2004; Pang et al., 2002; Talwar et al., 2017; Tuteja 
et al., 2014). 
 Most DEAD-box helicases, including DDX43, Ded1p, and Mss116p, unwind a 
nucleic acid double strand with no strict directionality.  DDX43 unwinds a nucleic acid double 
strand by a translocation mechanism irrespective of 3′→5′ or 5′→3′ directionality (Talwar et 
al., 2017; Wu et al., 2019).  Ded1p and Mss116p unwind a nucleic acid double strand through 
local strand separation in either the external strand 3′→5′ or 5′→3′ directionality or in concert 
with the internal strand (Yang et al., 2007).  By comparison, we showed that DDX59 is a 
3′→5′ DNA helicase.  Our results on the DNA helicase activity of DDX59 on progressively 
increasing length of the double-strand DNA (Figure 13I) is sensitive to the stability of nucleic 
acid sequence suggestive of a passive helicase (Lionnet et al., 2007; Lohman and Bjornson, 
1996; Manosas et al., 2010).  Importantly, we further showed that the DNA unwinding activity 
of DDX59 requires ATP hydrolysis (Figure 14). 
 DDX59 shows ineffective RNA helicase activities in vitro for the double-stranded 
RNA substrates tested in this study, which is unexpected as most DEAD-box helicases are 
supposed to unwind RNA (Jarmoskaite and Russell, 2011).  The varied helicase activity 
within the DEAD-box family might stem from their accessory domain(s) in their N- and C-
termini. DDX59 is one of six human zinc-finger HIT family proteins (ZNHIT1-6) that contain 
the ZNHIT motif (Verheggen et al., 2015).  This motif in ZNHIT6 has no direct RNA binding 
capacity (Bragantini et al., 2016).  Investigation of the role of the ZNHIT motif in DDX59 is 
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needed.  Additionally, this varied helicase activity can be accomplished by oligomerization 
(Liu et al., 2008a) or the presence of a cofactor (Pang et al., 2002).  For example, the founding 
member of the DEAD-box helicase, elF4A, is thought to use its RNA unwinding capability 
to unravel secondary structures in mRNA during translation initiation (Abramson et al., 1988; 
Pause et al., 1993; Ray et al., 1985; Rozen et al., 1990).  However, elF4A requires another 
initiation factor elF4B for enhanced helicase activity (Grifo et al., 1984; Pause et al., 1993; 
Ray et al., 1985).  Although we observed some residual RNA unwinding activities at low 
concentrations of DDX59, these activities did not conclude effective RNA helicase activity 
for DDX59 (Figure 12C).  It is possible to speculate that, like elF4A, DDX59 requires one 
or more additional cofactors to enhance its helicase activity on double-stranded RNA. 
5.2. Role of DDX59 in ciliogenesis as an OFDS-associated gene 
Identifying new regulators of cilia will help in providing insight into the molecular 
mechanism and new animal models for cilia-related diseases.  Most of the OFDS-associated 
genes identified localized to the ciliary compartment with canonical functions in regulating 
cilia signaling and ciliogenesis (Bruel et al., 2017; Franco and Thauvin-Robinet, 2016). 
 Previous studies have reported that DDX59 localized to the nucleus and cytosol, with 
no reports on interference on ciliogenesis (Faily et al., 2017; Salpietro et al., 2018; Shamseldin 
et al., 2013).  Understanding the role of DDX59 in ciliogenesis remains an enigma.  One 
possibility is that DDX59 depletion disturbs the transcription of gatekeeper genes that localize 
around the transition zone.  This could lead to the imbalance in the localization of proteins 
that control key ciliogenesis processes, such as those involved in the assemble of the transition 
zone from the basal body.  Similarly, it could disturb ciliogenesis via replication initiation 
factors.  For example, the loss of components of the minichromosome maintenance (MCM) 
protein complex disturbs faithful ciliogenesis by promoting the transcription of a subset of 
genes, which causes ciliary shortening and centrosome over-duplication (Casar Tena et al., 
2019).  Of note, DDX59 depletion leads to the downregulation of MCM2 helicase protein 
levels (You et al., 2017).  Thus, our result on the effect of DDX59 depletion on ciliary 
formation presents a novel function of DDX59 as an OFDS-associated gene.  This new 
function could arise from an impact on centrosomes.  The centrosome is indispensable for 
ciliogenesis as it comprises the basal body, from which the axoneme elongates (Bettencourt-
Dias et al., 2011; Rosenbaum and Witman, 2002). 
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 Increasing evidence suggests an increasing connection between congenital diseases in 
genes encoding proteins with canonical roles in DNA repair, DNA damage response 
signaling, or DNA replication with impaired ciliary function (Johnson and Collis, 2016).  For 
example, defects in OFD1 gene that underlie the OFDS-I subtype is known to cause profound 
impairment in DNA repair functions as well as ciliary formation and signaling; impairments 
which plausibly contribute to the clinical presentation of OFDS-I subtype (Abramowicz et al., 
2017).  The DNA damage response apical kinase ATR, often mutated in Seckel syndrome 
(O’Driscoll et al., 2003), has been shown to regulate ciliary signaling and formation (Stiff et 
al., 2016).  Similar non-canonical function in non-replicating cells is established for MCM2 
pre-replicative complex to govern faithful ciliogenesis in resting cells (Casar Tena et al., 
2019).  Therefore, accumulating evidence demonstrates the complex and mutual functional 
interactions between DNA damage response, DNA repair, or DNA replication with 
components that regulate ciliary formation and functions.  Thus, DDX59 helicase shown to 
have a canonical role in DNA replication (You et al., 2017), as an OFDS-associated gene, 
also confer a role in ciliogenesis. 
 Collectively, the role of DDX59 in regulating ciliary formation may contribute to the 
clinical manifestation of DDX59 helicase in OFDS.  Whereas, it is difficult to uncouple the 
influence of the specific cellular defect on ciliogenesis described here from the DNA helicase 
activities of DDX59; it is in agreement with the cellular characteristics of OFDS-associated 
genes as ciliopathies-associated genes. 
5.3. Molecular pathogenesis of OFDS caused by DDX59 mutations 
Our findings of reduced DDX59 helicase activity shown for the missense mutations may have 
implications not just in defective helicase, but also in transcriptional regulation.  These could 
have complex adverse impacts during development via altered ciliogenesis that may also 
influence the clinical features presented by DDX59 mutations associated with OFDS.  The 
missense mutations biochemically characterized in this study and the nonsense mutations of 
DDX59 in OFDS are known to impact on cilia through defective Shh signaling (Table 5). 
(Faily et al., 2017; Salpietro et al., 2018; Shamseldin et al., 2013). 
Table 5.  DDX59 mutations in OFDS and their ciliary or Shh signaling. 
DDX59 mutations in OFDS Shh signaling Ciliogenesis Reference 
F62fs*13 Yes Unknown (Salpietro et al., 2018) 
V367G Yes Unclear (Shamseldin et al., 2013) 
G534R Unknown Unknown (Shamseldin et al., 2013) 
*619fs*22 Yes Unknown (Faily et al., 2017) 
44 
 
 The OFDS-associated DDX59 patients samples showed reduced mRNA and protein 
expression without complete defect in nonsense-mediated decay (Faily et al., 2017; Salpietro 
et al., 2018; Shamseldin et al., 2013).  Finally, the two deleterious mutations reported, are 
presented with a more severe clinical manifestation, including microcephaly and skeletal 
abnormalities (Faily et al., 2017; Salpietro et al., 2018), and there is mounting evidence that 
cilia function during skeletogenesis.  Because microcephaly is a hallmark of severe structural 
brain defect, it is in agreement with our findings and also supports the possibility that DDX59 
loss of helicase activity mutations might be susceptible to severe clinical features than reduced 
helicase activity mutations.  Of note, the family history of the patient with deleterious 
F62fs*13 mutation was unremarkable, except for three prior spontaneous miscarriages 
(Salpietro et al., 2018). 
 Together, these revelations suggest that these missense mutations are hypomorphic 
for DDX59 helicase activity, and in each case, the mutations must allow sufficient residual 
protein function to enable embryogenesis and patient viability explaining the recessive nature 
of these mutations in OFDS.  Thus, the residual helicase activities displayed by the missense 
DDX59 mutations in OFDS might support ciliogenesis, but insufficient to ensure the correct 
regulation of cilia function via defective helicase activities.  Further investigations of 
mutations in OFDS are needed to understand their molecular pathogenesis and contribution 
to OFDS. 
6. CONCLUSIONS AND FUTURE DIRECTIONS 
In conclusion, we have successfully expressed recombinant DDX59 protein in E. coli cells 
and purified it using Nickel affinity and size exclusion chromatography.  Helicase assays 
showed that DDX59 efficiently unwinds double-stranded DNA with a 3′→5′ direction, and 
the activity depends on the hydrolysis of ATP.  DDX59 ineffectively unwind double-stranded 
RNA substrates.  We have successfully generated RPE1 cell line deficient in DDX59 using 
the CRISPR-Cas9 system and showed that ciliation in these cells reduced drastically, which 
is consistent with ciliary formation defect pathogenesis observed for most OFDS-associated 
genes mutations.  We also found that DDX59 missense mutations in OFDS compromise the 
DDX59 DNA helicase activities. 
 We have found that DDX59 is a DNA helicase and deficiency in its helicase activity 
implicates DDX59 in the pathogenesis of OFDS through defective ciliogenesis and ciliary 
function.  This study biochemically characterized DDX59 for the first time as a DNA helicase 
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and extends our knowledge on the cellular characteristics of OFDS-associated genes as 
ciliopathies-associated genes by adding DDX59 to the set of genes in the ciliome database. 
 In the future, to determine DDX59 and DDX59-OFDS mutants’ impact on 
transcription of genes required for ciliary formation, and their centrosome and ciliary 
localization, we will: 1) Generate RPE1 model cell line harboring OFDS-associated DDX59 
mutations by CRISPR/Cas9 system, 2) Use the RPE1 model cell lines to study the effect on 
ciliogenesis by counting cilia forming cells and measuring cilia length using high resolution 
immunofluorescence microscopy, 3) Use the RPE1 model cell lines to compare the cell cycle 
dependent localization of DDX59 (WT vs. mutant) to the centrosome and cilia using 
immunofluorescence, and 4) Use the RPE1 model cell lines to compare the differential impact 
on cilia related genes using transcriptomic approach. 
 In our current study, we detected a residual RNA helicase activity for DDX59.  We 
suspect that DDX59 might require co-factor(s) to initiate and/or stimulate its unwinding 
activity on RNA substrate.  To identify the protein cofactor, the following objectives need to 
be realized: 1) To generate inducible HEK293-Fln cell line over-expressing 3xFlag tagged 
DDX59, 2) To purify 3xFlag tagged DDX59 complexes using affinity chromatography, 3) To 
separate the different 3xFlag tagged DDX59 protein complexes by size exclusion 
chromatography, 4) To analyze the RNA helicase activity of the various eluted fractions from 
size exclusion chromatography, and 5) To identify the potential co-factor by mass 
spectrometry from the fraction that depicts the highest RNA helicase activity. 
 To investigate the function of the ZNHIT motif in DDX59, we will: 1) Examine 
helicase activity of DDX59 mutants by site-directed mutagenesis, 2) Test the DNA helicase 
activity of ZNHIT motif truncated DDX59, 3) Re-check the RNA helicase and nuclease 
activity of ZNHIT motif truncated DDX59 using different substrates.  Because we found that 
DDX59 has a weak RNA helicase activity at lower protein concentrations and nuclease 
activity at higher protein concentrations, and the RNA nuclease activity seems to occur in the 
U-rich loading strand, and 4) Investigate the RNA and DNA binding activities of ZNHIT 
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